NIH-CPSI Chronic Prostatitis Symptom Score Calculator

The NIH-CPSI chronic prostatitis symptom score turns weeks of vague pelvic pain and urinary trouble into one number you and your doctor can act on. This validated nine-question index scores pain, urinary symptoms, and quality of life, then sorts your result into a mild, moderate, or severe band with a plain-English plan for each. It takes about two minutes. For more, see the UTIs and infections hub.

Medically reviewed by

Dr. Muhammad Khalid

MBBS, FCPS (Urology), MCPS (Gen. Surgery), CHPE, CRSM · IMC #539472

Last updated

July 22, 2026

ValidatedNIH Chronic Prostatitis Symptom Index (NIH-CPSI)

Used WorldwideThe standard prostatitis symptom measure

9 QuestionsTakes about 2 minutes

The Tool

Related UTI & Prostatitis Tools

Decision Tool UTI Risk Assessment for Men Checks whether your symptoms point to a urinary infection. Open Tool → Checker UTI vs STI Symptom Checker Sorts overlapping urinary and genital symptoms apart. Open Tool → Calculator Post-Void Residual Estimator Estimates how much urine is left after you void. Open Tool → Decision Tool CP/CPPS UPOINT Phenotype Classifier Maps your symptoms to the domains that direct treatment. Open Tool → Likert IPSS Prostate Symptom Score Scores urinary symptoms of an enlarged prostate. Open Tool →

Full Clinical Guide

In This Guide:

Key Takeaways

The NIH-CPSI is a validated 9-question index scoring pain, urinary symptoms, and quality of life, for a total of 0 to 43.
Bands are mild 0-14, moderate 15-26, and severe 27-43 – your domain breakdown matters as much as the total.
A high score reflects symptom burden, not danger: chronic pelvic pain syndrome does not damage the prostate or shorten life.
A fall of about 6 points on a repeat score is a meaningful sign that treatment is working.

What This Tool Measures

The NIH-CPSI chronic prostatitis symptom score is the standard way to measure how much chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) are affecting you. It is a nine-question index developed and validated by Litwin and colleagues through the National Institutes of Health Chronic Prostatitis Collaborative Research Network, tested against men with benign prostatic enlargement and healthy controls [1]. The questionnaire produces a single total from 0 to 43, built from three separate domains: pain (0 to 21), urinary symptoms (0 to 10), and quality of life (0 to 12) [2]. It measures how you have felt over the past week, so it captures the day-to-day reality of the condition rather than a one-off bad moment.

The Physiology Behind the Score

Most men who score on this index have what the NIH consensus calls category III prostatitis – chronic pelvic pain syndrome with no active bacterial infection to treat [3]. Think of the pelvic floor as a set of muscles that can go into a low, constant spasm, much like a shoulder that stays knotted after months of tension. That tightness irritates the nerves running through the perineum and refers pain to the testicles, the tip of the penis, and the bladder area. The same tension can drive urinary symptoms – a stop-start stream or a feeling of not emptying fully – which is why the index scores urinary complaints alongside pain. If your urinary points are high, the Post-Void Residual Estimator can help gauge whether your bladder is actually emptying. The score does not diagnose the cause; it measures the burden so the right cause can be pursued.

Prostatitis symptoms are usually a pain syndrome driven by pelvic floor tension and irritated nerves – not an infection sitting in the prostate waiting for the next antibiotic.

How to Interpret Your Result

Total scores are grouped as mild (0 to 14), moderate (15 to 26), and severe (27 to 43), thresholds drawn from a multinational study of more than 1,500 men [2]. But the total is only half the story. A man who scores 8 because of mild, occasional aching and a man who scores 8 because of severe pain on just a few days need very different plans – which is why the pain, urinary, and quality-of-life breakdown sits beside your total. Reading your result means asking two questions: how high is the total, and which domain is driving it? A score built almost entirely from pain points toward the pelvic floor and nerves; one built from urinary points toward the bladder and outflow. For what treatment actually looks like once you know your band, this guide walks through the options.

What to Do With Your Result

A mild score usually calls for conservative steps first: cutting triggers such as prolonged cycling, caffeine, and alcohol, warm sitz baths, and 5 to 10 minutes of daily pelvic floor relaxation, then a repeat score in 4 to 6 weeks. A moderate or severe score is where the domain split changes the plan. Pain-predominant results point toward pelvic floor physiotherapy and a low-dose neuromodulator such as amitriptyline; urinary-predominant results point toward an alpha-blocker like tamsulosin and bladder retraining. The reason this matters is that sequential single-drug trials – the classic run of one antibiotic after another – fail most men, because category III disease has no infection to clear. Guideline-backed care instead treats two or three targets at once, matched to your phenotype [4]. The UPOINT Phenotype Classifier maps exactly which domains are active for you, and pelvic floor dysfunction is one of the most treatable of them.

If you are unsure about your result, the PDF report this tool generates gives you a ready-made framework to bring to your next appointment.

In My Practice

The single most common thing I see with this condition is the fear that it is cancer. A man in his thirties with months of a perineal ache and a completely normal examination has often spent weeks convinced something is being missed. The relief when the CPSI reframes it as a pain syndrome, not a tumor, is a treatment in itself.

Naming the condition accurately – chronic pelvic pain syndrome, not an infection and not cancer – is often the first real step toward getting the symptoms down.

References

Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol. 1999;162(2):369-375. PubMed.
Wagenlehner FME, van Till JWO, Magri V, et al. NIH-CPSI symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome (n=1563); total-score severity categories mild 0-14, moderate 15-26, severe 27-43. Eur Urol. 2013;63(5):953-959. PubMed.
Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236-237. JAMA.
European Association of Urology. Guidelines on Chronic Pelvic Pain (prostate pain syndrome; UPOINT phenotype-directed multimodal therapy). EAU Guidelines.
Propert KJ, Litwin MS, Wang Y, et al. Responsiveness of the NIH Chronic Prostatitis Symptom Index (NIH-CPSI); an approximately 6-point change is clinically meaningful. Qual Life Res. 2006;15(2):299-305. PubMed.
Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population-based study using the NIH Chronic Prostatitis Symptom Index. J Urol. 2001;165(3):842-845. PubMed.

Frequently Asked Questions

What is a normal NIH-CPSI score, and what counts as severe?

The total runs from 0 to 43. Based on a large multinational study, scores are grouped as mild (0 to 14), moderate (15 to 26), and severe (27 to 43). There is no single normal number, because men without prostatitis usually score very low. What matters more than the exact total is which domain – pain, urinary, or quality of life – is driving it, since that decides which treatments to try first. For what those treatments look like, see chronic prostatitis and CPPS treatment.

Does a high CPSI score mean I have an infection or prostate cancer?

No. A high score measures how much your symptoms bother you, not the cause. Most men who score have category III chronic pelvic pain syndrome, which has no active bacterial infection to treat, and the CPSI has nothing to do with prostate cancer risk. If you are unsure whether an infection or a sexually transmitted cause could be involved, the UTI vs STI Symptom Checker can help sort the overlapping symptoms apart before you see your doctor.

How is the NIH-CPSI different from the IPSS?

The two scores answer different questions. The IPSS measures the urinary symptoms of an enlarged prostate, such as a weak stream and frequent night-time urination. The NIH-CPSI is pain-led: its largest domain scores where and how badly you hurt, and urinary symptoms are only one part. A man can have a high CPSI from pelvic pain while his IPSS stays low, or the reverse. Using the right index keeps the plan matched to the real problem.

How accurate is this tool, and can I rely on it?

The NIH-CPSI is a validated questionnaire used worldwide in clinics and research, so the score itself is reliable when you answer honestly about the past week. What it cannot do is diagnose the cause of your symptoms or replace an examination and, where needed, a urine test. Treat your result as an accurate measure of symptom burden and a starting point for the conversation, not as a diagnosis on its own.

How do I use this result at my doctor’s appointment?

Use the Download My Report button to generate a two-page PDF with your total, your pain, urinary, and quality-of-life breakdown, an interpretation, and a short list of questions to ask. Bringing your domain breakdown lets your doctor see at a glance which symptoms are driving the score and match treatment to them, rather than starting from scratch. If you retake the score later, bring both reports so the change can be measured against your starting number.

Dr. Muhammad Khalid

MBBS · FCPS (Urology) · MCPS (Gen. Surgery) · CHPE · CRSM · IMC #539472

Specialist urologist with 11+ years of clinical experience across tertiary teaching hospitals. Trained at Lady Reading Hospital and Khyber Teaching Hospital, Peshawar. Author of 5 peer-reviewed international publications in Cureus, WJSA, and AJBS. Procedural expertise: URS, PCNL, RIRS, TURP, TURBT, and major open urological surgery. Full profile →

This article is for educational purposes only and does not constitute medical advice. Always consult your physician or urologist for diagnosis and treatment decisions specific to your condition.